New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD exacerbation with a dry powder inhaler vs. a metered-dose or soft mist ...

Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD and co-morbidities.

The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five years. This growth is driven by the rising prevalence of respiratory diseases ...

Chronic obstructive pulmonary disease, commonly called COPD, is a long-term lung condition that makes breathing difficult. It usually develops after many years of exposure to harmful particles, ...

Approval marks the second regulatory approval outside of the U.S. Food and Drug Administration, further expanding access to COPD patients in select Special Administrative Regions (SARs) in Greater Chi ...

Chronic respiratory diseases such as asthma account for 4% of all deaths in South Africa and poverty is the main underlying ...

Chronic obstructive pulmonary disease (COPD) has become one of the world’s most lethal but least prioritised health crises.

Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies using inhaled insulin ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads ...

AS a Saharan dust plume descends on the UK, millions could be left “coughing and wheezing” or suffering a dangerous health ...

MIAMI – Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of lack of affordability and lack of knowledge about medications, among other factors, ...